
- 1D
- 1W
- 1M
- 1Y
- 5Y
- YTD
About Terns Pharma
Terns Pharmaceuticals, Inc. operates as a biopharmaceutical company. The Company discovers and develops molecularly-targeted and oral molecule drugs for the treatment of liver disease and cancer. Terns Pharmaceuticals serves customers worldwide.
Stock Analysis

last close
$2.36
1-mo return
34.9%
3-mo return
-13.6%
avg daily vol.
184.75T
52-week high
13.77
52-week low
1.45
market cap.
$68M
forward pe
-
annual div.
-
roe
-29.9%
ltg forecast
-
dividend yield
-
annual rev.
$1M
inst own.
92.9%